Aesthetic injectables and skincare company scaling sales infrastructure globally
Evolus is a public performance beauty company (NASDAQ: EOLS) built around injectable and topical aesthetic products. The tech stack reflects a sales-execution focus: Salesforce as the CRM spine, with dbt and Snowflake for analytics, paired with Microsoft enterprise infrastructure (Azure, Teams, SharePoint). Hiring velocity is accelerating—35 active roles with 22 posted in the last 30 days—but the department mix is heavily sales-concentrated (21 roles) versus only 2 engineering seats, indicating a company scaling go-to-market into new geographies (Germany, Italy, UK, Austria, Australia, Ireland) rather than building product.
Evolus develops injectable and skincare aesthetic products sold to dermatologists, plastic surgeons, and aesthetic practitioners. Founded in 2014 and headquartered in Newport Beach, California, the company operates as a public entity (NASDAQ: EOLS) with 201–500 employees. The business model combines product delivery with provider education and account management, as evidenced by projects around healthcare provider training programs and national account initiatives. International expansion is a current priority: the company is actively hiring across seven countries and executing a strategic rollout of systems integration to support multi-region operations.
Salesforce for CRM, Snowflake and dbt for data analytics, Azure Entra ID and Microsoft 365 (Teams, SharePoint, OneDrive, Exchange) for enterprise infrastructure, plus Git for version control and Google Analytics for web tracking.
Yes. Active projects include Australian market expansion, international systems integration, and HQ visits. The hiring footprint spans seven countries, and pain points explicitly cite expanding into Australia and establishing global IT security and reliability.
Other companies in the same industry, closest in size